The Brigance Brigade has doubled its client base as ALS diagnoses rise across all age groups, providing crucial support for ...

The advocacy group I AM ALS secured $313 million in federal funding for its campaign to accelerate research and expand access to treatment.

As many state legislatures across the country begin their 2026 sessions, the ALS Association released its annual ALS State Policy Report Cards, evaluating how all 50 states and Washington, D.C. are ...

While many people know about the disease ALS and the devastating effects it can have, little has been known about the roots of amyotrophic lateral sclerosis — until now. The exact cause of ALS — also ...

I AM ALS announced a major milestone in its Push for Progress campaign: thanks to our community of advocates and partners, we've secured $313 million in funding for ALS research in the 2026 federal ...

ALS Association yearly report cards show no U.S. state earned the highest score for policies supporting patients; several had ...

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, ...

CAMBRIDGE, Mass., July 1, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NRSN) (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe ...

A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration. The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on ...

Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) are both diseases that affect your central nervous system. While they have some overlapping symptoms, ...

Brooke Eby and Dray are back to enjoying walks together with help from Chewy Claus Kelli Bender is the Pets Editor at PEOPLE. She has been working at PEOPLE since 2013. Her work has previously ...